ARCHIVES

Zometa Can Reduce Risk Of Skeletal-Related Events

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975

Oncology Unit – How To Plan, Start It

February 10, 1978

President Sppointed John Niederhuber NCI Director.

September 8, 2006